MedPath

Manual Diaphragm Release in Cleaning Laborer

Not Applicable
Completed
Conditions
Respiratory System Abnormalities
Interventions
Other: Manual Diaphragm Release
Other: control group
Registration Number
NCT05802355
Lead Sponsor
Maged Basha
Brief Summary

This study intended to examine the effect of manual diaphragm release on pulmonary function, chest wall mobility, and functional ability in female occupational cleaners with respiratory hazards.

Detailed Description

Cleaning chores have been linked to exposure to various chemical agents that have the potential to cause harmful effects on both the respiratory system and cardiovascular markers, many cleaning products and disinfectants contain ingredients that can act as airway irritants. One of the physical therapy procedures that is used to manage chest disorders is manual diaphragm release which aims to lengthen the diaphragm musculature whereas encouraging better and more proficient contraction.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
36
Inclusion Criteria
  • Female occupational cleaners.
  • Age between 35 and 45.
  • Had work-related respiratory hazards.
  • Clinically stable.
  • No exacerbation in the previous 6 weeks.
  • Working in an occupation with respiratory hazards for at least 2 years.
  • Mild to moderate air way obstruction.
  • Willingness to participate in this study and provide a consent form.
Exclusion Criteria
  • Other cardiopulmonary diseases.
  • Body mass index > 30 kg/ m2.
  • Previous thoracic or abdominal surgery.
  • Smokers and users of tobacco in any form (chewing, snuffing or water pipe).
  • Systemic conditions (e.g., diabetes mellitus, hypertension).
  • Sever airway obstructions.
  • Inability to perform the required exercises.
  • Inability to attend the scheduled sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Manual Diaphragm ReleaseManual Diaphragm Releasereceived 3sessions/ week for 12 consecutive weeks.
control groupcontrol groupreceived 3sessions/ week for 12 consecutive weeks.
Primary Outcome Measures
NameTimeMethod
Forced vital capacityafter 12 weeks

measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards

Serum IgEafter 12 weeks

The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm.

Forced expiratory volume in one secondafter 12 weeks

measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards

pulmonary expiratory flowafter 12 weeks

measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards

Secondary Outcome Measures
NameTimeMethod
Functional performanceafter 12 weeks

Assessed using the 6-minute walk test

Chest wall mobilityafter 12 weeks

measured using tape measurement with maximum inspiration and expiration and the difference between them has been recorded in (cm).

Trial Locations

Locations (1)

Outpatient Clinic of College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University

🇸🇦

Al-Kharj, Riyadh, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath